- Home
- FCAP vs RCEL Comparison
FCAP vs RCEL Comparison
Compare FCAP & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCAP
- RCEL
- Stock Information
- Founded
- FCAP 1891
- RCEL N/A
- Country
- FCAP United States
- RCEL United States
- Employees
- FCAP N/A
- RCEL N/A
- Industry
- FCAP Savings Institutions
- RCEL Medical/Dental Instruments
- Sector
- FCAP Finance
- RCEL Health Care
- Exchange
- FCAP Nasdaq
- RCEL Nasdaq
- Market Cap
- FCAP 125.9M
- RCEL 107.8M
- IPO Year
- FCAP 1999
- RCEL N/A
- Fundamental
- Price
- FCAP $44.01
- RCEL $3.41
- Analyst Decision
- FCAP
- RCEL Buy
- Analyst Count
- FCAP 0
- RCEL 5
- Target Price
- FCAP N/A
- RCEL $11.80
- AVG Volume (30 Days)
- FCAP 3.6K
- RCEL 256.9K
- Earning Date
- FCAP 10-24-2025
- RCEL 11-06-2025
- Dividend Yield
- FCAP 2.79%
- RCEL N/A
- EPS Growth
- FCAP 25.19
- RCEL N/A
- EPS
- FCAP 4.41
- RCEL N/A
- Revenue
- FCAP $47,323,000.00
- RCEL $74,884,000.00
- Revenue This Year
- FCAP N/A
- RCEL $20.40
- Revenue Next Year
- FCAP N/A
- RCEL $32.94
- P/E Ratio
- FCAP $9.69
- RCEL N/A
- Revenue Growth
- FCAP 15.22
- RCEL 38.32
- 52 Week Low
- FCAP $28.50
- RCEL $3.37
- 52 Week High
- FCAP $53.85
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- FCAP 57.27
- RCEL 28.65
- Support Level
- FCAP $42.71
- RCEL $3.37
- Resistance Level
- FCAP $44.00
- RCEL $3.91
- Average True Range (ATR)
- FCAP 0.80
- RCEL 0.23
- MACD
- FCAP 0.20
- RCEL -0.04
- Stochastic Oscillator
- FCAP 100.00
- RCEL 3.98
About FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.